Advertisement
Screener

Indaptus Therapeutics, Inc. (INDP) Auditor

Indaptus Therapeutics, Inc. Auditor

The independent registered public accounting firm that signed the audit report in each annual report on Form 10-K, newest first. PCAOB firm ID and the internal-control attestation are as tagged on the cover from fiscal 2021; earlier rows come from the signed report text.

  • 2026-03-17: Fiscal year end 2025-12-31; Auditor Haskell & White LLP; PCAOB firm ID 200; Location Irvine, California.
  • 2025-03-13: Fiscal year end 2024-12-31; Auditor HASKELL & WHITE LLP; PCAOB firm ID 200; Location Irvine, California.
  • 2024-03-13: Fiscal year end 2023-12-31; Auditor HASKELL & WHITE LLP; PCAOB firm ID 200; Location Irvine, California.
  • 2023-03-17: Fiscal year end 2022-12-31; Auditor Haskell & White LLP; PCAOB firm ID 200; Location Irvine, California.
FiledFiscal year endAuditorPCAOB firm IDLocationInternal-control attestation
2026-03-172025-12-31Haskell & White LLP200Irvine, CaliforniaNo
2025-03-132024-12-31HASKELL & WHITE LLP200Irvine, CaliforniaNo
2024-03-132023-12-31HASKELL & WHITE LLP200Irvine, CaliforniaNo
2023-03-172022-12-31Haskell & White LLP200Irvine, CaliforniaNo
2022-03-212021-12-31HASKELL & WHITE LLP200Irvine, CaliforniaNo

Similar stocks

Stock NameCountryMarket CapPE Ratio
CRESCENT BIOPHARMA, INC. (CBIO)United States$0.529B-5.20
Evolus, Inc. (EOLS)United States$0.519B-13.32
ARVINAS, INC. (ARVN)United States$0.510B58.38
PUMA BIOTECHNOLOGY, INC. (PBYI)United States$0.507B15.53
Phathom Pharmaceuticals, Inc. (PHAT)United States$0.572B-8.76
CAPRICOR THERAPEUTICS, INC. (CAPR)United States$0.499B-10.81
Ovid Therapeutics Inc. (OVID)United States$0.487B-14.41
ASSEMBLY BIOSCIENCES, INC. (ASMB)United States$0.481B-13,053.96
Altimmune, Inc. (ALT)United States$0.593B-6.43
Monopar Therapeutics (MNPR)United States$0.598B-34.82